ArticleMolecular diversity2026
Structural insights into the structure-activity relationships of flavonoids targeting WSSV and LvGSTMu.
Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
White spot syndrome virus (WSSV) represents one of the most severe threats to shrimp aquaculture worldwide, with no effective antiviral treatments currently available. In this study, the antiviral and antioxidant potential of the flavonoids amentoflavone, agathisflavone, and apigenin was investigated using an integrated in silico approach combining molecular docking, pharmacophore analysis, and Normal Mode Analysis (NMA)-based molecular dynamics. Docking simulations revealed that all flavonoids bind favorably to WSSV thymidylate synthase (wTS) and to the glutathione S-transferase from L. vannamei (LvGSTmu), with binding affinities superior to those of the co-crystallized ligands. Amentoflavone showed the highest affinity toward wTS, preserving key catalytic interactions and closely mimicking the binding mode of the native substrate. Pharmacophore analysis highlighted the importance of aromatic centers and hydrogen bond donor/acceptor groups in stabilizing ligand-protein complexes. NMA-based dynamics demonstrated that amentoflavone and apigenin confer increased structural stability to wTS and LvGSTmu, respectively, reducing conformational fluctuations without compromising protein integrity. Molecular dynamics simulations confirmed the stability of the complexes throughout the 200 ns simulation, while MM/GBSA analysis revealed favorable binding free energies, supporting stable interactions with wTS. Overall, these results suggest that flavonoids, particularly amentoflavone, represent promising scaffolds for the development of antiviral and antioxidant agents against WSSV, warranting further experimental validation.
Indexed as
Identifiers
42530801What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.